8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Mar 27, 2026·SEC
Material company update
Feb 25, 2026·SEC
Amarin Corporation plc(AMRN)Earnings, Financials & Key Ratios
AMRN•NASDAQ
Price updated Jun 19, 2026
AboutAmarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.Show more
- Revenue$214M-6.5%
- EBITDA-$11M+87.7%
- Net Income-$39M+52.8%
- EPS (Diluted)-1.80+55.0%
- Gross Margin56.57%+58.9%
- EBITDA Margin-5.11%+86.8%
- Operating Margin-6.53%+83.7%
- Net Margin-18.16%+49.5%
- ROE-8.21%+48.2%
AMRN Key Insights
Amarin Corporation plc (AMRN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.7x book value
✗Weaknesses
- ✗Profits declining 16.6% over 5 years
- ✗Sales declining 19.0% over 5 years
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when AMRN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AMRN Price & Volume
Amarin Corporation plc (AMRN) stock price & volume — 10-year historical chart
Loading chart...
AMRN Growth Metrics
Amarin Corporation plc (AMRN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years10.08%
5 Years-19.04%
3 Years-16.67%
TTM0.33%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM61.77%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM62.14%
Return on Capital
10 Years-25.59%
5 Years-9.12%
3 Years-10.38%
Last Year-2.84%
AMRN Recent Earnings
Amarin Corporation plc (AMRN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 29, 2026Metric
Actual
Est
EPS
$0.09-1000.0%
$0.01
Rev
$45M+3.1%
$44M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.01-85.7%
$0.07
Rev
$49M-2.8%
$51M
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$0.01-87.5%
$0.08
Rev
$49M-4.1%
$51M
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$0.03+95.5%
$0.66
Rev
$47M+10.9%
$42M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.09vs $0.01-1000.0% | $45Mvs $44M+3.1% |
| Q1 2026 | Feb 25, 2026 | $0.01vs $0.07-85.7% | $49Mvs $51M-2.8% |
| Q4 2025 | Oct 29, 2025 | $0.01vs $0.08-87.5% | $49Mvs $51M-4.1% |
| Q3 2025 | Jul 30, 2025 | $0.03vs $0.66+95.5% | $47Mvs $42M+10.9% |
Based on last 12 quarters of dataView full earnings history →
AMRN Peer Comparison
Amarin Corporation plc (AMRN) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ELAN | 12.1B | 24.22 | -51.53 | 6.22% | -4.95% | -3.64% | 0.61 | |
 ACAD | 3.7B | 21.62 | 9.44 | 11.87% | 34.3% | 35.65% | 0.04 | |
 SUPN | 2.56B | 44.38 | -65.26 | 8.63% | -3.74% | -2.73% | 0.04 | |
 HRMY | 1.93B | 33.28 | 12.28 | 21.51% | 16.2% | 17.19% | 0.28 | |
 PRGO | 1.42B | 10.25 | -1.00 | -2.75% | -43.5% | -50.65% | 1.35 | |
 PAHC | 1.29B | 31.85 | 26.76 | 27.37% | 6.29% | 30.81% | 2.67 | |
 ABBV | 383.17B | 216.63 | 91.41 | 8.57% | 6.91% | 62.15% | ||
 PFE | 143.46B | 25.22 | 18.54 | -1.65% | 11.83% | 8.34% | 0.78 |
Compare AMRN vs Peers
Amarin Corporation plc (AMRN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMRN Income Statement
Amarin Corporation plc (AMRN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 181.1M | 229.21M | 429.75M | 614.06M | 583.19M | 369.19M | 306.91M | 228.61M | 213.65M | 214.88M |
Revenue Growth % | 39.22% | 26.56% | 87.49% | 42.89% | -5.03% | -36.69% | -16.87% | -25.51% | -6.55% | 0.33% |
Cost of Goods Sold | 44.95M | 54.54M | 96.02M | 131.44M | 121.33M | 126.71M | 141.37M | 147.23M | 92.78M | 102.11M |
COGS % of Revenue | 24.82% | 23.8% | 22.34% | 21.41% | 20.8% | 34.32% | 46.06% | 64.4% | 43.43% | - |
Gross Profit | 136.15M▲ 0% | 174.67M▲ 28.3% | 333.74M▲ 91.1% | 482.62M▲ 44.6% | 461.86M▼ 4.3% | 242.48M▼ 47.5% | 165.54M▼ 31.7% | 81.38M▼ 50.8% | 120.87M▲ 48.5% | 112.77M▲ 0% |
Gross Margin % | 75.18% | 76.2% | 77.66% | 78.59% | 79.2% | 65.68% | 53.94% | 35.6% | 56.57% | 52.48% |
Gross Profit Growth % | 42.24% | 28.29% | 91.07% | 44.61% | -4.3% | -47.5% | -31.73% | -50.84% | 48.52% | - |
Operating Expenses | 181.71M | 282.9M | 358.01M | 502.27M | 451.36M | 348.35M | 233.13M | 173.18M | 134.81M | 150.13M |
OpEx % of Revenue | 100.33% | 123.42% | 83.31% | 81.8% | 77.4% | 94.36% | 75.96% | 75.75% | 63.1% | - |
Selling, General & Admin | 134.55M | 227M | 323.62M | 463.31M | 408.33M | 304.42M | 199.94M | 152.31M | 115M | 99.52M |
SG&A % of Revenue | 74.29% | 99.03% | 75.3% | 75.45% | 70.02% | 82.45% | 65.15% | 66.62% | 53.83% | - |
Research & Development | 47.16M | 55.9M | 34.39M | 38.96M | 29.31M | 30.41M | 22.22M | 20.87M | 19.81M | 18.45M |
R&D % of Revenue | 26.04% | 24.39% | 8% | 6.34% | 5.03% | 8.24% | 7.24% | 9.13% | 9.27% | - |
Other Operating Expenses | 74K | -326K | 0 | 104K | 13.72M | 13.53M | 10.97M | 0 | 0 | 2M |
Operating Income | -45.55M▲ 0% | -108.22M▼ 137.6% | -24.28M▲ 77.6% | -19.66M▲ 19.0% | 10.5M▲ 153.4% | -105.87M▼ 1108.1% | -67.59M▲ 36.2% | -91.8M▼ 35.8% | -13.94M▲ 84.8% | -37.36M▲ 0% |
Operating Margin % | -25.15% | -47.22% | -5.65% | -3.2% | 1.8% | -28.68% | -22.02% | -40.15% | -6.53% | -17.38% |
Operating Income Growth % | 30.58% | -137.57% | 77.57% | 19.05% | 153.43% | -1108.08% | 36.16% | -35.82% | 84.81% | - |
EBITDA | -44.84M | -107.56M | -23.42M | -17.6M | 13.36M | -102.77M | -64.62M | -88.78M | -10.91M | -34.42M |
EBITDA Margin % | -24.76% | -46.92% | -5.45% | -2.87% | 2.29% | -27.84% | -21.06% | -38.84% | -5.11% | -16.02% |
EBITDA Growth % | 30.86% | -139.87% | 78.23% | 24.85% | 175.9% | -869.32% | 37.12% | -37.39% | 87.71% | 62.58% |
D&A (Non-Cash Add-back) | 715.59K | 667.87K | 859K | 2.05M | 2.86M | 3.1M | 2.96M | 3.01M | 3.03M | 2.93M |
EBIT | -45.05M | -107.3M | -15.86M | -14.76M | 11.42M | -103.79M | -53.88M | -77.19M | -36.04M | -5.19M |
Net Interest Income | -9.34M | -7.8M | 1.87M | 2.3M | 1.09M | 2.8M | 11.86M | 13.4M | 10.85M | 10.41M |
Interest Income | 429K | 1.07M | 8.5M | 4.9M | 1.22M | 2.82M | 11.86M | 13.4M | 10.85M | 10.41M |
Interest Expense | 9.77M | 8.87M | 6.63M | 2.6M | 129K | 15K | 8K | 7K | 7K | 0 |
Other Income/Expense | -9.26M | -8.12M | 1.8M | 2.4M | 789K | 2.06M | 13.92M | 14.6M | -22.11M | 2.64M |
Pretax Income | -55.41M▲ 0% | -116.35M▼ 110.0% | -22.48M▲ 80.7% | -17.25M▲ 23.2% | 11.29M▲ 165.4% | -103.81M▼ 1019.4% | -53.67M▲ 48.3% | -77.2M▼ 43.8% | -36.05M▲ 53.3% | -34.72M▲ 0% |
Pretax Margin % | -30.59% | -50.76% | -5.23% | -2.81% | 1.94% | -28.12% | -17.49% | -33.77% | -16.87% | -16.16% |
Income Tax | 13.05M | 96K | 164K | 745K | 3.56M | 2M | 5.44M | 4.98M | 2.75M | -1.11M |
Effective Tax Rate % | -23.55% | -0.08% | -0.73% | -4.32% | 31.55% | -1.92% | -10.14% | -6.45% | -7.63% | 3.18% |
Net Income | -67.86M▲ 0% | -116.44M▼ 71.6% | -22.64M▲ 80.6% | -18M▲ 20.5% | 7.73M▲ 142.9% | -105.8M▼ 1468.9% | -59.11M▲ 44.1% | -82.18M▼ 39.0% | -38.8M▲ 52.8% | -33.61M▲ 0% |
Net Margin % | -37.47% | -50.8% | -5.27% | -2.93% | 1.33% | -28.66% | -19.26% | -35.95% | -18.16% | -15.64% |
Net Income Growth % | 21.41% | -71.58% | 80.55% | 20.51% | 142.94% | -1468.91% | 44.13% | -39.03% | 52.79% | 61.77% |
Net Income (Continuing) | -68.59M | -116.44M | -22.64M | -18M | 7.73M | -105.8M | -59.11M | -82.18M | -38.8M | -33.61M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -5.00▲ 0% | -7.80▼ 56.0% | -1.32▲ 83.1% | -1.00▲ 24.2% | 0.38▲ 138.0% | -5.20▼ 1468.4% | -3.00▲ 42.3% | -4.00▼ 33.3% | -1.80▲ 55.0% | -1.62▲ 0% |
EPS Growth % | 39.02% | -56% | 83.08% | 24.24% | 138% | -1468.42% | 42.31% | -33.33% | 55% | 62.14% |
EPS (Basic) | -5.00 | -7.80 | -1.32 | -0.94 | 0.39 | -5.20 | -3.00 | -4.00 | -1.80 | - |
Diluted Shares Outstanding | 13.53M | 14.86M | 17.13M | 19.09M | 20.12M | 20.06M | 20.38M | 20.55M | 20.75M | 20.8M |
Basic Shares Outstanding | 13.53M | 14.86M | 17.13M | 18M | 19.8M | 20.06M | 19.7M | 20.55M | 20.75M | 20.8M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
AMRN Balance Sheet
Amarin Corporation plc (AMRN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 153.27M | 378M | 855M | 879.23M | 878.73M | 689.1M | 724.98M | 595.4M | 649.88M | 626.02M |
Cash & Short-Term Investments | 73.64M | 249.23M | 644.59M | 500.93M | 454.13M | 309.36M | 320.66M | 294.22M | 302.79M | 307.82M |
Cash Only | 73.64M | 249.23M | 644.59M | 186.96M | 219.45M | 217.67M | 199.25M | 121.04M | 134.86M | 131.06M |
Short-Term Investments | 0 | 0 | 0 | 313.97M | 234.67M | 91.69M | 121.41M | 173.18M | 167.93M | 176.76M |
Accounts Receivable | 45.32M | 66.52M | 116.43M | 154.57M | 163.65M | 130.99M | 133.56M | 122.28M | 126.83M | 108.05M |
Days Sales Outstanding | 91.33 | 105.93 | 98.89 | 91.88 | 102.43 | 129.5 | 158.84 | 195.23 | 216.68 | 204.39 |
Inventory | 30.26M | 57.8M | 76.77M | 188.86M | 234.68M | 228.73M | 258.62M | 166.05M | 195.91M | 183.59M |
Days Inventory Outstanding | 245.7 | 386.81 | 291.82 | 524.45 | 706 | 658.89 | 667.71 | 411.65 | 770.73 | 657.21 |
Other Current Assets | 600K | 1.5M | 3.91M | 3.92M | 3.92M | 20.02M | 525K | 12.85M | 24.35M | 26.56M |
Total Non-Current Assets | 8.33M | 7.72M | 27.2M | 86.79M | 189.34M | 197.08M | 106.7M | 89.95M | 20.89M | 19.75M |
Property, Plant & Equipment | 28K | 63K | 10.87M | 10.07M | 9.09M | 9.95M | 8.42M | 7.61M | 6.47M | 6.01M |
Fixed Asset Turnover | 6468.00x | 3638.32x | 39.53x | 60.98x | 64.19x | 37.11x | 36.43x | 30.05x | 33.01x | 31.44x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.36M | 0 |
Intangible Assets | 8.13M | 7.48M | 15.26M | 13.82M | 23.55M | 21.78M | 19.3M | 16.39M | 0 | 12.73M |
Long-Term Investments | -1.74M | 0 | 0 | 62.47M | 35M | 1.27M | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 174K | 174K | 1.07M | 432K | 121.71M | 164.08M | 78.97M | 65.95M | 1.05M | 1.01M |
Total Assets | 161.6M▲ 0% | 385.71M▲ 138.7% | 882.21M▲ 128.7% | 966.02M▲ 9.5% | 1.07B▲ 10.6% | 886.18M▼ 17.0% | 831.68M▼ 6.1% | 685.35M▼ 17.6% | 670.77M▼ 2.1% | 645.76M▲ 0% |
Asset Turnover | 1.12x | 0.59x | 0.49x | 0.64x | 0.55x | 0.42x | 0.37x | 0.33x | 0.32x | 0.32x |
Asset Growth % | -3.23% | 138.69% | 128.72% | 9.5% | 10.56% | -17.03% | -6.15% | -17.59% | -2.13% | -31.95% |
Total Current Liabilities | 108.53M | 157.26M | 242.25M | 307.44M | 370.68M | 259.48M | 259.28M | 179.95M | 194.46M | 179.64M |
Accounts Payable | 25.16M | 37.63M | 49.95M | 105.88M | 114.92M | 64.6M | 52.76M | 40.37M | 45.35M | 48.15M |
Days Payables Outstanding | 204.25 | 251.83 | 189.88 | 294 | 345.73 | 186.09 | 136.22 | 100.07 | 178.43 | 156.32 |
Short-Term Debt | 22.83M | 34.24M | 50.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue (Current) | 1.64M | 1.22M | 2.34M | 2.93M | 2.65M | 2.2M | 2.34M | 0 | 0 | 0 |
Other Current Liabilities | 5.16M | 72M | 16.59M | 28.79M | 45.6M | 35.64M | 185.23M | 139.58M | 149.1M | 131.49M |
Current Ratio | 1.41x | 2.40x | 3.53x | 2.86x | 2.37x | 2.66x | 2.80x | 3.31x | 3.34x | 3.48x |
Quick Ratio | 1.13x | 2.04x | 3.21x | 2.25x | 1.74x | 1.77x | 1.80x | 2.39x | 2.33x | 2.46x |
Cash Conversion Cycle | 132.79 | 240.91 | 200.83 | 322.32 | 462.69 | 602.3 | 690.33 | 506.8 | 808.99 | 705.28 |
Total Non-Current Liabilities | 118.17M | 76.12M | 31.7M | 31.07M | 30.28M | 31.37M | 20.31M | 19.22M | 17.03M | 16.71M |
Long-Term Debt | 99.83M | 46.11M | 0 | 0 | 0 | 0 | 0 | 0 | 6.08M | 5.58M |
Capital Lease Obligations | 0 | 0 | 9.44M | 9.15M | 8.58M | 10.02M | 8.74M | 7.72M | 6.08M | 13.42M |
Deferred Tax Liabilities | 1.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1.15M | 10.52M | 3.75M | 6.21M | 7.65M | 8.21M | 9.06M | 11.5M | 4.87M | 11.12M |
Total Liabilities | 226.7M | 233.38M | 273.95M | 338.52M | 400.97M | 290.85M | 279.59M | 199.17M | 211.49M | 196.35M |
Total Debt | 122.66M | 80.35M | 59.57M | 9.15M | 8.58M | 10.02M | 8.74M | 7.72M | 12.16M | 5.58M |
Net Debt | 49.02M | -168.88M | -585.01M | -177.81M | -210.88M | -207.65M | -190.51M | -113.31M | -122.7M | -125.48M |
Debt / Equity | - | 0.53x | 0.10x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.03x | 0.01x |
Debt / EBITDA | - | - | - | - | 0.64x | - | - | - | - | -0.16x |
Net Debt / EBITDA | - | - | - | - | -15.79x | - | - | - | - | 3.65x |
Interest Coverage | -4.61x | -12.09x | -2.39x | -5.67x | 88.52x | -6919.33x | -6734.75x | -11027.57x | -5148.71x | - |
Total Equity | -65.1M▲ 0% | 152.33M▲ 334.0% | 608.26M▲ 299.3% | 627.5M▲ 3.2% | 667.1M▲ 6.3% | 595.33M▼ 10.8% | 552.1M▼ 7.3% | 486.18M▼ 11.9% | 459.28M▼ 5.5% | 449.41M▲ 0% |
Equity Growth % | -618.7% | 333.99% | 299.31% | 3.16% | 6.31% | -10.76% | -7.26% | -11.94% | -5.53% | -40.05% |
Book Value per Share | -4.81 | 10.25 | 35.52 | 32.87 | 33.15 | 29.68 | 27.09 | 23.66 | 22.13 | 21.61 |
Total Shareholders' Equity | -65.1M | 152.33M | 608.26M | 627.5M | 667.1M | 595.33M | 552.1M | 486.18M | 459.28M | 449.41M |
Common Stock | 208.77M | 246.66M | 269.17M | 290.12M | 294.03M | 299M | 302.76M | 305.3M | 310.18M | 314.06M |
Retained Earnings | -1.27B | -1.39B | -1.41B | -1.43B | -1.42B | -1.53B | -1.59B | -1.67B | -1.71B | -1.72B |
Treasury Stock | -4.23M | -10.41M | -35.9M | -51.08M | -60.73M | -61.77M | -63.75M | -65.33M | -67.36M | 0 |
Accumulated OCI | -816K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AMRN Cash Flow Statement
Amarin Corporation plc (AMRN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -32.84M | -94.7M | -9.37M | -21.75M | -66.53M | -179.98M | 6.91M | -31.02M | 6.74M | 25.56M |
Operating CF Margin % | -18.13% | -41.32% | -2.18% | -3.54% | -11.41% | -48.75% | 2.25% | -13.57% | 3.16% | - |
Operating CF Growth % | 54.28% | -188.4% | 90.11% | -132.18% | -205.94% | -170.53% | 103.84% | -549.13% | 121.74% | 644.22% |
Net Income | -67.86M | -116.44M | -22.64M | -18M | 7.73M | -105.74M | -59.34M | -82.18M | 0 | -33.61M |
Depreciation & Amortization | 708K | 669K | 859K | 2.04M | 2.86M | 3.09M | 2.98M | 3.01M | 0 | -97.21K |
Stock-Based Compensation | 13.96M | 18.81M | 30.92M | 45.81M | 0 | 0 | 0 | 17.7M | 0 | -3.95M |
Deferred Taxes | 11.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 2.33M | 2.18M | 1.64M | 2.24M | 38.86M | 26.67M | 12M | -5.73M | -25.54M | -22.77M |
Working Capital Changes | 6.95M | 84K | -20.14M | -53.83M | -115.98M | -104.01M | 51.27M | 36.17M | 32.28M | 47.14M |
Change in Receivables | -25.33M | -21.2M | -49.91M | -39.47M | -8.34M | 32.98M | -2.33M | 11.22M | -3.83M | -1.05M |
Change in Inventory | -9.75M | -27.54M | -18.97M | -112.09M | -167.05M | -36.4M | 56.34M | 105.44M | 34.96M | 33.22M |
Change in Payables | 40.27M | 37.6M | 65.91M | 114.74M | 51.51M | -102.67M | -164.63K | -77.02M | 14.54M | 17.22M |
Cash from Investing | -12K | -58K | -2.48M | -376.96M | 104.09M | 175.18M | -25.62M | -45.98M | 8.85M | -11.72M |
Capital Expenditures | -12K | -58K | -2.48M | -252K | 0 | -598.63K | -535.07K | 0 | 0 | 0 |
CapEx % of Revenue | 0.01% | 0.03% | 0.58% | 0.04% | 0% | 0.16% | 0.17% | - | - | 0% |
Acquisitions | 0 | 0 | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | -58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -200.5M |
Cash from Financing | 8.23M | 271.25M | 409.61M | -58.91M | -5.07M | -378.77K | 230.89K | -1.44M | -2.04M | -2.59M |
Debt Issued (Net) | 11.57M | -14.69M | -31.65M | -50.34M | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | -2.77M | 264.84M | 440.11M | 0 | 4.57M | 664.59K | 2.22M | 131.06K | 140.33K | 140.33K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -2.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -569K | 21.1M | 1.16M | -8.57M | -9.64M | -1.04M | -1.99M | -1.57M | -2.18M | -2.73M |
Net Change in Cash | -24.61M▲ 0% | 176.49M▲ 817.0% | 397.77M▲ 125.4% | -457.62M▼ 215.0% | 32.49M▲ 107.1% | -5.18M▼ 116.0% | -18.41M▼ 255.2% | -78.44M▼ 326.0% | 13.52M▲ 117.2% | 11.44M▲ 0% |
Free Cash Flow | -32.85M▲ 0% | -94.76M▼ 188.5% | -11.84M▲ 87.5% | -22M▼ 85.7% | -66.53M▼ 202.4% | -179.98M▼ 170.5% | 6.88M▲ 103.8% | -31.02M▼ 550.7% | 6.74M▲ 121.7% | 25.51M▲ 0% |
FCF Margin % | -18.14% | -41.34% | -2.76% | -3.58% | -11.41% | -48.75% | 2.24% | -13.57% | 3.16% | 11.87% |
FCF Growth % | 54.27% | -188.47% | 87.5% | -85.73% | -202.43% | -170.53% | 103.82% | -550.7% | 121.74% | 182.56% |
FCF per Share | -2.43 | -6.38 | -0.69 | -1.15 | -3.31 | -8.97 | 0.34 | -1.51 | 0.33 | 1.23 |
FCF Conversion (FCF/Net Income) | 0.48x | 0.81x | 0.41x | 1.21x | -8.61x | 1.70x | -0.12x | 0.38x | -0.17x | -0.76x |
Interest Paid | 17.24M | 21.53M | 4.59M | 2.04M | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 1.75M | 850K | 67K | 207K | 0 | 0 | 0 | 3.98M | 0 | 3.31M |
AMRN Key Ratios
Amarin Corporation plc (AMRN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | -266.98% | -5.95% | -2.91% | 1.19% | -16.76% | -10.3% | -15.83% | -8.21% | -7.34% |
Return on Invested Capital (ROIC) | - | - | -543.64% | -6.23% | 1.74% | -18.82% | -13.53% | -18.75% | -2.95% | -8.44% |
Gross Margin | 75.18% | 76.2% | 77.66% | 78.59% | 79.2% | 65.68% | 53.94% | 35.6% | 56.57% | 52.48% |
Net Margin | -37.47% | -50.8% | -5.27% | -2.93% | 1.33% | -28.66% | -19.26% | -35.95% | -18.16% | -15.64% |
Debt / Equity | - | 0.53x | 0.10x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.03x | 0.01x |
Interest Coverage | -4.61x | -12.09x | -2.39x | -5.67x | 88.52x | -6919.33x | -6734.75x | -11027.57x | -5148.71x | - |
FCF Conversion | 0.48x | 0.81x | 0.41x | 1.21x | -8.61x | 1.70x | -0.12x | 0.38x | -0.17x | -0.76x |
Revenue Growth | 39.22% | 26.56% | 87.49% | 42.89% | -5.03% | -36.69% | -16.87% | -25.51% | -6.55% | 0.33% |
Related:AMRN Dividend History·AMRN Revenue History·AMRN Price History·AMRN P/E History·AMRN Financial Ratios·AMRN Institutional Holders
AMRN SEC Filings & Documents
Amarin Corporation plc (AMRN) SEC filings — annual & quarterly reports (10-K, 10-Q)
AMRN Frequently Asked Questions
Amarin Corporation plc (AMRN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Amarin Corporation plc (AMRN) reported $214.9M in revenue for fiscal year 2025. This represents a 899% increase from $21.5M in 1996.
Amarin Corporation plc (AMRN) saw revenue decline by 6.5% over the past year.
Amarin Corporation plc (AMRN) reported a net loss of $33.6M for fiscal year 2025.
Dividend & Returns
Amarin Corporation plc (AMRN) has a return on equity (ROE) of -8.2%. Negative ROE indicates the company is unprofitable.
Amarin Corporation plc (AMRN) generated $25.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.